SHOCKING: Culper research | Mind Blowing Facts

Short Seller Alleges Praxis Precision's Potential $3 Billion Drug 'A House Of Cards'

A short seller is challenging Praxis Precision Medicines Inc. (NASDAQ:PRAX) after the company claimed success from its Phase 3 trial of ulixacaltamide.

Benzinga · Nov 20, 2025

DoorDash's Most Active Dashers Are 'Unauthorized Workers:' Culper Shorts DASH Saying 10-11% Pay Raise Would 'Wipe Out' 2024 EBITDA

Short-seller Culper Research has initiated a short position in DoorDash Inc. (NASDAQ:DASH), alleging in a new report that the company’s financial success is built on a “supply crisis” solution: a “backdoor” system for onboarding unauthorized workers.

Benzinga · Oct 27, 2025

Archer Aviation Stock Steadies After Short-Seller Report

Archer Aviation's stock shows resilience after a short-seller report, as investors shift to the upcoming milestones and flight demonstrations for validation.

MarketBeat · May 30, 2025